- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02766010
A Comparative Clinical Study to Assess the Accuracy of TensorTip MTX, a Non Invasive Device
January 26, 2020 updated by: Cnoga Medical Ltd.
A Comparative Clinical Study to Assess the Accuracy of TensorTip MTX, a Non Invasive Device for the Measurement of Physiological and Hematological Parameters
- Aim- This study is aimed to access the accuracy of TensorTip MTX device measuring Hemoglobin A1C, Oxygen Concentration and Saturation ,Carbon Dioxide, Blood pH, Hemoglobin, Hematocrit, Red Cells Count, platelets, Blood Urea Nitrogen, Sodium, Potassium, Chloride, total bilirubin, cholesterol (HDL, LDL), Serum Creatinine, Peripheral Pulse Rate, Blood Pressure, Mean Arterial Pressure, cardiac output, cardiac index, stoke volume and blood gases compared with the simultaneous results from hospital references device (when available)
- Hypothesis- Human physiological biomarkers may be measured from the color distribution of the internal or external (skin) tissue. The technology of the TensorTip device is based on the color distribution of the peripheral blood tissue, which enables the measurement of certain biomarkers and vital signs under consideration
Study Overview
Detailed Description
- This is a comparative clinical trial in which the measurements obtained by the TensorTip device will be compared with those obtained by the reference devices used by the hospital on daily or periodic monitoring (the devices will be identified by name and version at the final report).
- Eligible real time color signal obtained by the TensorTip during the measurement shall be recorded simultaneously with the measurements obtained by the reference devices (as described in the above point).
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female, age > 18
- Agree to sign voluntary inform consent.
Exclusion Criteria:
- Refusal to sign an informed consent and to participate in the study.
- Below the age of 18.
- Finger size not suitable for the measurement chamber.
- Injured skin in the measurement site.
- Long fingernails
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: group A TensorTip
Male or female, age > 18
|
Non Invasive screening of various physiological and hematological parameters.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
blood pressure measurement of the TensorTip against hospital readings
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 22, 2016
Primary Completion (Actual)
August 29, 2016
Study Completion (Actual)
August 29, 2016
Study Registration Dates
First Submitted
March 28, 2016
First Submitted That Met QC Criteria
May 6, 2016
First Posted (Estimate)
May 9, 2016
Study Record Updates
Last Update Posted (Actual)
January 28, 2020
Last Update Submitted That Met QC Criteria
January 26, 2020
Last Verified
April 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- CM-CL-P-PHY-002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Pressure
-
GE HealthcareRecruitingBlood Pressure Measurement | Blood PressureFinland
-
GE HealthcareCompleted
-
Taiwan Biophotonic CorporationCompletedBlood Pressure | Blood Pressure VariabilityTaiwan
-
Université de SherbrookeRecruitingBlood Pressure | Blood Pressure Monitoring, Ambulatory | Blood Pressure, High | Blood Pressure ManagementCanada
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
DongGuk UniversityActive, not recruitingHypertension | Blood Pressure | Ambulatory Blood Pressure | Home Blood Pressure MeasurementKorea, Republic of
-
University of JordanCompletedBlood Pressure | Heart Rate | Airway PressureJordan
-
Sky LabsSamsung Medical CenterRecruitingHypertension | Blood Pressure | Hypotension | Blood Pressure, High | Blood Pressure, LowKorea, Republic of
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
Centre Hospitalier Universitaire VaudoisRecruitingBlood Pressure | Blood Pressure DisordersSwitzerland